Continuing Education – Webinars

Education developed by hematology experts!  Earn Section 1 MOC credits.

International Perspectives in CLL Management

The educational program provides insights on managing CLL from a Canadian and International perspective. The content has been designed to improve the knowledge and skills of clinicians who manage patients with CLL .

Practical treatment strategies including evidence based best practices aligned with guideline recommendations will be discussed.

Presenters will engage in a clinical exchange to address key clinical questions in CLL.

May 18, 2022 at 12-1 PM ET

Speakers:
Dr Peter Hillmen
, MBChB, PhD, FRCP, FRCPath

Professor of Experimental Hematology, University of Leeds
Honorary Consultant Hematologist, Leeds Teaching Hospitals NHS Trust

Dr. Carolyn Owen, FRCPC

Hematologist, Associate Professor
University of Calgary and Tom Baker Cancer Centre
Calgary, Alberta

Objectives

  • Determine patient characteristics from recently reported and ongoing clinical trials conducted among patients with CLL
  • Evaluate safety and efficacy data from recent clinical trials that impact practice in the care of patients with CLL
  • Place recent clinical trial results in their proper clinical context given evolving treatment paradigms in CLL management

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Pathologists (CAP-AC). You may claim a maximum of 1.0 hours.

This webinar was co-developed with Astra Zeneca and the CHS and was planned to achieve scientific integrity, objectivity and balance. This webinar is for CHS members and offered on a complimentary basis.

Free Registration for CHS Members.  Not a member yet? Join Now!

Clinical Cases to Enhance Knowledge – For Patients with Chronic Lymphocytic Leukemia

Friday, June 3, 2022 12:00-1:00 PM ET  REGISTRATION COMING SOON!

Dr. Nicole Laferriere – Hematologist, Regional Cancer Program. Systemic Therapy Regional Quality Lead, Cancer Care Ontario. Medical Director & Chief of Oncology, Regional Cancer Care Northwest. Associate Professor, Northern Ontario School of Medicine

 

Dr. Chai Phua – Assistant Professor of Medicine, Western University and Medical Co-Director of Coagulation Laboratory, Victoria Hospital.

 

Dr. Sue Robinson – Hematologist, QEII Health Sciences Centre. Professor, Dalhousie University

Current Landscape in Management of CLL including recent Updates on Preventative Approaches to Manage Risk of COVID-19 in Patients

April 19, 2022 – 7:00-8:00PM ET – this session will be posted on the CHS Member Portal in May to review and receive Section 3 MOC Self-Assessment Credits

Speaker: Dr. Carolyn Owen, Associate Professor, Division of Hematology & Hematological Malignancies, University of Calgary. Hematologist, Tom Baker Cancer Centre

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Pathologists (CAP-AC). You may claim a maximum of 1.0 hours.

These co-developed webinars were supported via an unrestricted educational grant from AstraZeneca Canada Inc.  The CHS Scientific Planning Committee ensured they were planned to achieve scientific integrity, objectivity and balance.